arrow
C

Clemens Schulte

carl gustav carus university hospital
H指数:13
被引数:1,067

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of Haematology
2026-01-010
PRE
High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of Haematology

高预处理外周血T细胞受体克隆性可预测免疫性血小板减少症对英国血液学杂志的反应延长

2026-01-010
OAAI
Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study

评估接受帕博利珠单抗治疗的转移性NSCLC患者中人工智能辅助数字症状监测可行性的德国单臂观察性试点研究

2025-07-150
OA
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study

真性红细胞增多症高风险患者在接受一线治疗效果不佳后切换至鲁索利替尼治疗与非切换者的临床结局比较:PV-Switch研究的结果

2025-07-040
OA
eSylites: Synthetic Probes for Visualization and Topographic Mapping of Single Excitatory Synapses

eSylites:用于可视化及拓扑映射单个兴奋性突触的合成探针

2025-03-200
PRE
Real-world treatment patterns and clinical outcomes in patients with locally advanced or metastatic urothelial carcinoma in Germany: retrospective CONVINCE study

德国局部晚期或转移性尿路上皮癌患者的真实世界治疗模式与临床结局:回顾性CONVINCE研究

2025-03-050
OA
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer
2024-10-230
OAAI
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naive to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
2023-10-044
OAAI
A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening
2022-11-099
OAAI